Reports for RANBAXY PHARMACEUTICALS CANADA INC.

Company Name

RANBAXY PHARMACEUTICALS CANADA INC.

Totals

Shortage reports

72

Actual shortage: 4 (6%)
Anticipated shortage: 0 (0%)
Avoided shortage: 0 (0%)
Resolved: 68 (94%)

Discontinuation Reports

32

To be discontinued: 0 (0%)
Discontinued: 32 (100%)
Reversed: 0 (0%)

Late reports

47 (45%)

Overdue reports

4 (100%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
RAN-ROPINIROLE 1.0MG TABLET Resolved 2019-02-11 2019-07-06 75268
RAN-ROPINIROLE 1.0MG TABLET Resolved 2020-05-27 2020-10-28 115893
RAN-ROPINIROLE 1.0MG TABLET Resolved 2022-01-06 2022-02-15 152163
RAN-ROPINIROLE 1.0MG TABLET Resolved 2022-08-19 2022-11-25 167426
RAN-ROPINIROLE 1.0MG TABLET Actual shortage 2022-12-13 2023-08-16 178240
RAN-ROPINIROLE 2.0MG TABLET Resolved 2019-02-11 2019-04-15 75271
RAN-ROPINIROLE 2.0MG TABLET Resolved 2019-05-28 2021-01-31 85084
RAN-ROPINIROLE 2.0MG TABLET Resolved 2021-10-21 2021-11-26 147748
RAN-ROPINIROLE 2.0MG TABLET Actual shortage 2022-08-19 2023-08-16 167429
RAN-ROPINIROLE 5.0MG TABLET Resolved 2019-02-11 2019-04-15 75274
RAN-ROPINIROLE 5.0MG TABLET Resolved 2020-12-03 2021-07-13 129547
RAN-ROPINIROLE 5.0MG TABLET Actual shortage 2022-08-19 2023-08-16 167432

Showing 61 to 72 of 72

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports

Showing 41 to 32 of 32